The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Clinical Study of Ivonescimab for First-line Treatment of Metastatic Squamous NSCLC Patients
Official Title: A Randomized, Controlled, Multiregional Phase 3 Study of Ivonescimab Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (HARMONi-3)
Study ID: NCT05899608
Brief Summary: This is a Phase 3 Randomized, Controlled, Multiregional Study of Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer. The primary endpoint is overall survival and key secondary endpoints include progression free survival. response and safety.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Summit Therapeutics Research Center, Los Angeles, California, United States
Summit Therapeutics Research Center, Los Angeles, California, United States
Summit Therapeutics Research Center, Sacramento, California, United States
Summit Therapeutics Research Center, Lone Tree, Colorado, United States
Summit Therapeutics Research Center, Fort Myers, Florida, United States
Summit Therapeutics Research Center, Jacksonville, Florida, United States
Summit Therapeutics Research Center, Ocala, Florida, United States
Summit Therapeutics Research Center, Palm Bay, Florida, United States
Summit Therapeutics Research Center, Pensacola, Florida, United States
Summit Therapeutics Research Center, Plantation, Florida, United States
Summit Therapeutics Research Center, Saint Petersburg, Florida, United States
Summit Therapeutics Research Center, Tallahassee, Florida, United States
Summit Therapeutics Research Center, West Palm Beach, Florida, United States
Summit Therapeutics Research Center, Burlington, Massachusetts, United States
Summit Therapeutics Research Center, Detroit, Michigan, United States
Summit Therapeutics Research Center, Saint Paul, Minnesota, United States
Summit Therapeutics Research Center, Billings, Montana, United States
Summit Therapeutics Research Center, Albany, New York, United States
Summit Therapeutics Research Center, Cincinnati, Ohio, United States
Summit Therapeutics Research Center, Cleveland, Ohio, United States
Summit Therapeutics Research Center, Eugene, Oregon, United States
Summit Therapeutics Research Center, Greenville, South Carolina, United States
Summit Therapeutics Research Center, Nashville, Tennessee, United States
Summit Therapeutics Research Center, Austin, Texas, United States
Summit Therapeutics Research Center, Dallas, Texas, United States
Summit Therapeutics Research Center, Harlingen, Texas, United States
Summit Therapeutics Research Center, Tyler, Texas, United States
Summit Therapeutics Research Center, Webster, Texas, United States
Summit Therapeutics Research Center, Norfolk, Virginia, United States
Summit Therapeutics Research Center, Reston, Virginia, United States
Summit Therapeutics Research Center, Spokane, Washington, United States
Summit Therapeutics Research Center, London, Ontario, Canada
Summit Therapeutics Research Center, Regina, Saskatchewan, Canada